Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.03% | $2.12M | €475.49B | 74.46% | 76 Outperform | |
| HSBC Holdings | 2.20% | $1.54M | £222.90B | 45.63% | 80 Outperform | |
| Roche Holding AG | 1.93% | $1.35M | CHF294.84B | 46.01% | 73 Outperform | |
| British American Tobacco | 1.59% | $1.11M | £94.19B | 54.10% | 71 Outperform | |
| Siemens | 1.51% | $1.06M | €191.01B | 9.25% | 74 Outperform | |
| Commonwealth Bank of Australia | 1.39% | $973.05K | AU$295.71B | 18.41% | 64 Neutral | |
| Sumitomo Electric Industries | 1.37% | $961.50K | ¥6.88T | 245.36% | 74 Outperform | |
| Novartis AG | 1.35% | $941.86K | CHF242.43B | 28.84% | 80 Outperform | |
| AstraZeneca | 1.34% | $937.64K | $323.92B | 30.42% | 80 Outperform | |
| Shell (UK) | 1.30% | $907.87K | £165.51B | 11.49% | 73 Outperform |